September 30, 2020

The Niche

Knoepfler lab stem cell blog

MSC exosomes

4 min read

Time to sell exosome therapies to patients? No. Some stem cell clinics and related firms are looking for new ways to make profits and toward that goal a few have latched onto the legitimate buzz around exosome research. What are exosomes? Imagine if you could bubble up a pea-sized sphere off your skin full of good stuff without harming yourself and toss it over to your relative or friend like a mini-water balloon toss, whose skin would fuse with it and absorb the goodies …Read More

4 min read

The recent news that Texas A&M University has inked a full-blown deal with the direct-to-consumer stem cell clinic firm Celltex struck me as an unusual development. Recently we’ve seen more universities exploring the use of stem cells outside of the traditional FDA clinical trial process that is fundamentally based on an investigational new drug application (IND). Some institutions apparently have even potentially started teaming up with clinics for patient treatments muddying the waters out there. However, in the case of Celltex and Texas A&M my guess …Read More

1 min read

The stem cell arena is a complicated universe with a whole range of things going on at any one time and there’s usually ample negative things, but not all is bad news. It’s interesting to regularly look specifically at the good stem cell news out there. Below is a look at some top pieces of good stem cell news and interesting recent papers. Ottawa to invest $20M in stem cell research  Piwi maintains germline stem cells and oogenesis in Drosophila through negative regulation of …Read More